State Street Corporation 13D and 13G filings for Celldex Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-01 10:22 am Sale |
2022-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
STATE STREET CORP STT |
2,291,454 4.870% |
-76,586 (-3.23%) |
Filing |
| 2022-02-10 1:29 pm Purchase |
2021-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
STATE STREET CORP STT |
2,368,040 5.070% |
2,368,040 (New Position) |
Filing |